HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dietary γ-Tocopherol-Rich Mixture Inhibits Estrogen-Induced Mammary Tumorigenesis by Modulating Estrogen Metabolism, Antioxidant Response, and PPARγ.

Abstract
This study evaluated the anticancer activity and mechanism of action of a γ-tocopherol-rich tocopherol mixture, γ-TmT, in two different animal models of estrogen-induced breast cancer. The chemopreventive effect of γ-TmT at early (6 weeks), intermediate (18 weeks), and late (31 weeks) stages of mammary tumorigenesis was determined using the August-Copenhagen Irish rat model. Female rats receiving 17β-estradiol (E2) implants were administered with different doses (0%, 0.05%, 0.1%, 0.3%, and 0.5%) of γ-TmT diet. Treatment with 0.3% and 0.5% γ-TmT decreased tumor volume and multiplicity. At 31 weeks, serum concentrations of E2 were significantly decreased by γ-TmT. γ-TmT preferentially induced expression of the E2-metabolizing enzyme CYP1A1, over CYP1B1 in the rat mammary tissues. Nrf2-dependent antioxidant response was stimulated by γ-TmT, as evident from enhanced expression of its downstream targets, NQO1, GCLM, and HMOX1. Serum concentrations of the oxidative stress marker, 8-isoprostane, were also decreased in the γ-TmT-treated groups. Treatment with γ-TmT increased expression of PPARγ and its downstream genes, PTEN and p27, whereas the cell proliferation marker, PCNA, was significantly reduced in γ-TmT-treated mammary tumors. In an orthotopic model in which human MCF-7 breast cancer cells were injected into the mammary fat pad of immunodeficient mice, γ-TmT inhibited E2-dependent tumor growth at all the doses tested. In conclusion, γ-TmT reduced mammary tumor development, in part through decreased E2 availability and reduced oxidative stress in mammary tissues; γ-TmT could thus be an effective agent for the prevention and treatment of E2-induced breast cancer.
AuthorsSoumyasri Das Gupta, Sudathip Sae-tan, Joseph Wahler, Jae Young So, Min Ji Bak, Larry C Cheng, Mao-Jung Lee, Yong Lin, Weichung Joe Shih, James D Shull, Stephen Safe, Chung S Yang, Nanjoo Suh
JournalCancer prevention research (Philadelphia, Pa.) (Cancer Prev Res (Phila)) Vol. 8 Issue 9 Pg. 807-16 (Sep 2015) ISSN: 1940-6215 [Electronic] United States
PMID26130252 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Copyright©2015 American Association for Cancer Research.
Chemical References
  • Antioxidants
  • Cdkn1b protein, rat
  • Estrogens
  • PPAR gamma
  • Proliferating Cell Nuclear Antigen
  • RNA, Messenger
  • Cyclin-Dependent Kinase Inhibitor p27
  • 8-epi-prostaglandin F2alpha
  • Estradiol
  • gamma-Tocopherol
  • Dinoprost
  • PTEN Phosphohydrolase
  • Pten protein, rat
Topics
  • Animals
  • Antioxidants (metabolism)
  • Cell Line, Tumor
  • Cyclin-Dependent Kinase Inhibitor p27 (metabolism)
  • Dinoprost (analogs & derivatives, chemistry)
  • Estradiol (administration & dosage)
  • Estrogens (metabolism)
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Immunoenzyme Techniques
  • Immunohistochemistry
  • MCF-7 Cells
  • Mammary Glands, Animal (metabolism)
  • Mammary Neoplasms, Animal (prevention & control)
  • Mammary Neoplasms, Experimental (prevention & control)
  • Mice
  • Mice, Nude
  • Neoplasm Transplantation
  • Oxidative Stress
  • PPAR gamma (metabolism)
  • PTEN Phosphohydrolase (metabolism)
  • Proliferating Cell Nuclear Antigen (metabolism)
  • RNA, Messenger (metabolism)
  • Rats
  • Time Factors
  • gamma-Tocopherol (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: